SLA Pharma is a niche biopharmaceutical company, specializing in gastrointestinal and allied disorders, with products in clinical development and already approved for human use. SLA Pharma is committed to improving the range of products available to treat gastrointestinal diseases worldwide. SLA Pharma AG is one of the few pharmaceutical companies in the world focused solely on developing medicines for the prevention and treatment of gastrointestinal (GI) disorders. This commitment to developing solutions for GI disorders has made SLA Pharma a world leader in the field through unrivalled development, medical, regulatory and commercial expertise in its therapeutic areas. We have extensive project experience and expertise in the following disease areas: gastroenterology, dermatology & colorectal oncology. We are currently running and recruiting clinical trials to test the efficacy & safety of: - Ortem to treat Pilonidal sinus disease - Alfa to treat Familial adenomatous polyposis & Ulcerative colitis - Anoheal to treat chronic anal fissures. SLA Pharma has offices in the United Kingdom and Switzerland To learn more, visit us at https://www.slapharma.com/
View Top Employees from SLA PharmaWebsite | http://www.slapharma.com |
Revenue | $5 million |
Employees | 9 (9 on RocketReach) |
Founded | 1997 |
Phone | +41 61 588 00 12 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Medical, Gastrointestinal, Manufacturing, Health Care, Licensing, Pharmaceutical, Digestive, Anal Fissure, Crohn's disease, Familial Adenomatous Polyposis, Constipation, Gastroenterology, Specialty Pharmaceuticals, Orphan Diseases, Alimentary, Partnering, Opioid Induced, FAP, Rectal, Business Development, Niche, Bowel, Cancer |
Web Rank | 14 Million |
Keywords | Sla Pharma, Sla Pharma Uk Ltd Watford |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular SLA Pharma employee's phone or email?
The SLA Pharma annual revenue was $5 million in 2024.
Chris Jordan is the Medical Director of SLA Pharma.
9 people are employed at SLA Pharma.
The NAICS codes for SLA Pharma are [325, 32, 32541, 3254].
The SIC codes for SLA Pharma are [283, 28].